USFDA Bans Ranbaxy's Punjab Facility
  • Prabha Hedge
  • Jan 24 2014

January 24: Ranbaxy has suffered a huge blow, as the U.S. FDA has barred its Punjab-based Toansa Active Pharmaceutical Ingredients (API) plant. Bloomberg TV India’s Agam Vakil shares more details on the same.